Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

6 Stocks Moving In Tuesday's After-Hours Session

NVAX, SLP

Gainers

  • IZEA Worldwide Inc (NASDAQ: IZEA) shares are up 16 percent after reporting first-quarter bookings of $7.8 million, up 18 percent year over year.
  • Simulations Plus, Inc. (NASDAQ: SLP) shares are up 10 percent after reporting a second-quarter earnings beat. Earnings came in at 12 cents, beating estimates by 2 cents. Sales came in at $8.472 million, beating estimates by $140,000.
  • Novavax, Inc. (NASDAQ: NVAX) shares are up 7 percent after reporting the company will present RSV maternal immunization program phase 3 data at the World Vaccine Congress.
  • Levi Strauss & Co. (NYSE: LEVI) shares are up 1 percent after reporting first-quarter earnings of 37 cents per share, up from $(0.05) year over year. Sales came in at $1.434 billion, up from $1.344 billion year over year. The company sees 2019 adjusted EBIT margin flat to slightly up, with sales growth in the mid-single-digit range.

Losers

  • Polarityte Inc (NASDAQ: PTE) shares are down 12 percent after reporting a common stock offering. The size was not disclosed.
  • WD-40 Company (NASDAQ: WDFC) shares are down 4 percent after reporting a second-quarter sales miss. Earnings came in at $1.14, beating estimates by 3 cents. Sales came in at $101.3 million, missing estimates by $2.8 million. The company reaffirms 2019 earnings and sales guidance.